Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- NKT cells
- Innate and adaptive immune cells
- NKT cells: definition and classification
- Thymic development of "type 1" or iNKT cells
- Signaling required for iNKT cell development
- T cell antigen receptors of iNKT cells
- Remarkable level of conservation of iNKT cell TCRs
- CD1d basic features
- iNKT cells: natural & synthetic glycolipid antigens
- Alpha-GalCer cancer activity immunological basis
- Binding of Alpha-GalCer to CD1d
- CD1d tetramers for identification of NKT cells
- Identification of iNKT cells in tissues
- Phenotypic subsets of iNKT cells defined by CD4
- Functional differences between iNKT subsets cells
- Bacterial glycolipids recognized by NKT cells
- What lipids are presented by CD1d to iNKT cells?
- Comparison of foreign and self antigen by CD1d
- Basic features of iNKT cells: review
- What do iNKT cells do?
- Response to strong antigenic stimulus
- Cytokine production by human iNKT cell clone
- iNKT cell recognition of bacterial glycolipids
- INKT activation following infection
- Direct versus indirect activation of iNKT cells
- iNKT cells contribute to resistance to infection
- Anti-cancer effects of iNKT cell activation (1)
- Anti-cancer effects of iNKT cell activation (2)
- Different tissue iNKT cell & anticancer activity
- Different phenotypic subsets & anticancer activity
- Response to weak antigenic stimulus
- Cytokine production by NKT cell clone DN2.D5
- Diverse potential outcomes of NKT cell activation
- Anti-inflammatory/regulatory effects of iNKT cells
- Reduced NKT cells levels in autoimmune diseases
- High expression of CD1d in spleen marginal zone
- NKT cells regulate B cells
- Enhanced anti-PC responses after immunization
- Lupus, MZ B cells and iNKT cells?
- iNKT cells regulate autoreactive B cell responses
- Therapeutic manipulation of NKT cells
- Synthetic analogues of alpha-GalCer KRN7000
- Alpha-GalCer analogues
- "TH2-like" bias: C20:2 and OCH analogues
- Prevention of autoimmune type 1 diabetes mellitus
- Overall summary and conclusions
- Acknowledgments
Topics Covered
- Definition of NKT cells and their relation to other innate-like lymphocytes
- Development of NKT cells
- Mechanisms of glycolipid antigen recognition by NKT cells
- Frequency and phenotype of NKT cells
- Foreign and self antigens recognized
- Proinflammatory functions (anti-infectious and anti-tumor activities)
- Anti-inflammatory and tolerance-promoting functions
- Manipulation of NKT cell responses and therapeutic opportunities
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Porcelli, S.A. (2012, April 5). CD1d-restricted NKT cells: regulators of inflammation and autoimmunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ZERQ5342.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Steven A. Porcelli, Consultant: Vaccinex, Inc. (Rochester, NY).
Hide